Proficio Capital Partners LLC purchased a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 36,360 shares of the company’s stock, valued at approximately $4,672,000.
Other institutional investors also recently bought and sold shares of the company. Stonebridge Capital Management Inc. purchased a new stake in shares of Merck KGaA in the second quarter valued at approximately $1,772,000. Pure Financial Advisors LLC purchased a new position in shares of Merck KGaA during the 2nd quarter valued at approximately $7,664,000. Payne Capital Management LLC acquired a new stake in Merck KGaA in the 2nd quarter valued at $1,642,000. Transamerica Financial Advisors LLC acquired a new stake in Merck KGaA in the 2nd quarter valued at $2,172,000. Finally, Corient Private Wealth LP purchased a new stake in Merck KGaA in the 2nd quarter worth $322,538,000. 0.10% of the stock is owned by institutional investors and hedge funds.
Merck KGaA Stock Performance
MKGAF opened at $164.58 on Thursday. The company has a market cap of $21.27 billion, a price-to-earnings ratio of 25.13 and a beta of 0.96. The firm’s fifty day simple moving average is $163.19 and its two-hundred day simple moving average is $148.83. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. Merck KGaA has a 52-week low of $116.68 and a 52-week high of $175.56.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Stories
- Five stocks we like better than Merck KGaA
- Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
- Alcoa’s Gallium Project Opens a New Door Beyond Aluminum
- Oura’s $16 Billion IPO Could Put a New Price on Wearable Tech
- Can Tesla’s Flying Roadster Distract From Its Real Risks?
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
